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Abstract 
In this study the forward and reverse primers were designated to amplify the segments (~250 
bps and ~650 bps) of the gene coding domains 1 and 4 of aerolysin of Aeromonas 
hydrophila. These two domains are involved in pathogenesis of the aerolysin gene. 
Sequences for two restriction enzymes, Pst I and Hind III, were included in the forward and 
reverse primers respectively. These restriction enzyme sites were used because they are not 
present within the genes of interest but are available in the multiple cloning sites of plasmid 
pNZ8048. Amplified PCR products were analyzed with 1% agarose gel electrophoresis and 
results showed that amplifications were very specific. In comparison with the DNA marker, 
the sizes of the amplified PCR products were determined to be approximately ~250 bps and 
~650 bps respectively. PCR products were then purified by the DNA purification kit, 
digested with REs and ligated with linearised pNZ8048 plasmid using T4 DNA ligase. 
Transformation of Lactococcus lactis NZ9000 cells was performed by the electroporation 
method. Verification for cloning of virulent genes was performed by REs digestion and also 
DNA sequencing. Since several antigens (bacterial and viral) and cytokines have been 
efficiently produced in L. lactis, constructing and expression and utilization of recombinant 
L. lactis harboring the aerolysin domains (virulent) genes from A. hydrophila may induce 
production of antibodies in fish against this pathogen. 
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Introduction 
Aeromonas hydrophila is frequently 
associated with disease in carp, eels, 
milkfish, channel catfish, tilapia, trout, ayu 
and a few other animals. This bacterium 
causes high mortality and great economic 
losses in freshwater fish farming 
worldwide. Many of the extracellular 
products (ECPs) are related to the 
virulence of this bacterium with 
cytotoxins, haemolysins (aerolysin) and 
proteases being the most important. 
Among them aerolysin is the most 
common virulence gene in almost all A. 
hydrophila strains. Antibiotic treatment of 
A. hydrophila has some disadvantages 
such as increase in plasmid-encoding 
antibiotic resistance and delay in fish sales 
as they need to be clear of the antibiotics 
before human consumption. In addition, 
antibiotic treatment is cost-prohibitive to 
farmers of many undeveloped and 
developing countries (Rahman et al., 1997; 
Vijai et al., 2009; Sasan 2010). 
Since several studies have shown 
that different vaccine formulations may 
provide protection, the immune 
prophylaxis against A. hydrophila becomes 
an attractive option. The antigenic 
diversity of A. hydrophila has posed a 
great difficulty in developing a vaccine, 
and at present, no vaccine for protection 
against A. hydrophila is commercially 
available. In this situation, the search for 
common protective antigens of A. 
hydrophila becomes critical for developing 
a common vaccine against this bacterium 
(Leung et al., 1997, 1998). One of the 
potential candidates of conserved antigens 
would be some extracellular products of 
this bacterium involved in the 
pathogenicity to fish. It may be possible to 
prevent A. hydrophila infection by 
blocking bacterial antigens (virulence 
genes) into fish with antibodies against 
aerolysin of A. hydrophila (Vaughan et al., 
1993; Zhu et al., 2007). 
Bacterial-based systems as live 
vectors for the delivery of heterologous 
antigens offer a number of advantages as a 
vaccination strategy. Using molecular 
biology, genetics and recombinant DNA 
techniques has allowed the insertion of 
genes encoding the antigens to be 
delivered into non-pathogenic carrier for 
expression (Liljeqvist and Stahle, 1999; 
Lee et al., 2001). Lactococcus lactis is 
among the Lactic Acid Bacteria (LAB) 
that are Gram-positive and designated 
Generally Recognized as Safe (GRAS) 
organisms. They are non-pathogenic, non-
invasive, non-colonising and they bare no 
threat to human and animal health (Wells 
et al., 1993; Raha et al., 2005). They also 
have the capacity to secrete proteins 
allowing surface expression or 
extracellular production of heterologous 
enzymes or proteins. Developments in 
genetic engineering have given these 
Gram-positive Lactic Acid Bacteria (LAB) 
the advantage to be used as a host 
expression system for antigen delivery to 
induce immune responses (Robinson et al., 
1997; Naima et al., 2007). 
In this study, cloning of domains 1 
and 4 of aerolysin gene from isolated A. 
hydrophila was carried out into L. lactis 
bacteria for the first time. Such safe, 
probiotic, genetically engineered and live 
recombinant bacteria harboring the foreign 
virulent genes may induce immune 
responses against pathogens in living 
things. 
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Materials and methods 
Bacterial Strains, Plasmids, Primers, 
and Growth Media 
The bacterial cells and plasmids used in 
this study are listed (Table 1). Aeromonas 
hyrophila AHMP  was isolated from 
diseased fish and cells were grown on 
Luria Bertani (LB) broth or LB agar 
solidified with 1.2% (w/v) bacteriological 
agar at 37º C. Lactococcus lactis NZ9000 
(host cells) and L. lactis pNZ8048 
(harboring pNZ8048 expression plasmids) 
cells were grown on SGM17 broth and 
SGM17 agar containing glucose (0.5 % 
w/v) and 0.5 M sucrose at 30º C. 
Chloramphenicol was used at a 
concentration of 7.5 µg/ml (Sasan et al., 
2007). Primers to amplify the full length 
segment of the gene coding for domains 1 
and 4 of aerolysin of A. hydrophila AHMP 
were designated according to the published 
sequences (Rossjohn et al., 1997, Wang et 
al., 2003). Sequences for two restriction 
enzymes, PstI and Hind III, were included 
in the forward and reverse primers 
respectively (Table 2). These restriction 
enzyme sites (REs) were used because 
they are not present within the genes of 
interest but are available in the multiple 
cloning sites (MCS) of plasmid pNZ8048. 
 
Table 1: Bacterial strains and plasmids 
Bacterial strains 
 and Plasmids  
 Features 
 
References 
 
Bacteria 
  
L. lactis NZ9000                        
 
MG1363 pepN::nisRK                             
 
Kuipers, 1998 
L. lactis NZ8048             
 
L. lactis
 
NZ9000 cells harboring 
pNZ8048 vector 
Kuipers, 1998 
 
A. hydrophila AHMP    
 
Isolated from diseased fish Sasan,  2007     
Plasmids   
pNZ 8048                        
 
Promoter: nisA, Antibiotic:Chlor., Expression 
vectorfor Lactococcus                       
Kuipers, 1998 
pNZ 8048D1Aer                             L. lactis plasmid carrying the Domain1 
of Aerolysin gene from A. hydrophila 
Current work 
pNZ 8048D4Aer                             L. lactis plasmid carrying the Domain 4 
of Aerolysin gene from A. hydrophila 
Current work 
 
 
Table 2: Primers used for amplification of two domains of aerolysin genes 
of  A. hydrophila AHMP 
Primers TM (°C) Sequences 
   
D1AerF 60 5’-ATGCTGCAGAAATGATGAATAGAATA 
ATTACCGC-3’ 
D1AerR 64 5’-ATGCAAGCTTGCCCCATAATCTCCCA 
GCGAT-3 
D4AerF 64 5’-ATGCTGCAGAAAACTCGCCATCGAGA 
TCGCT-3’ 
D4AerR 60 5’-ATGCAAGCTTGTTATTGAACCGGAAC 
TATGGTC-3’ 
* Underlined sequences: RE sites, CTGCAG; PstI and AAGCTT; HindIII 
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DNA Extraction and PCR Amplification 
Genomic DNA of A. hydrophila AHMP 
was extracted using the modified mini 
preparation method (Ausbel et al., 1987) 
with minor modification. PCR 
amplifications were performed using a pair 
of primers: D1AerF (5’- AT 
GCT………..3’) and D1AerR (5’-AT 
GCA………. -3’) to amplify a segment 
DNA, ~250-bp coding for domain1, a pair 
of primers: D4AerF (5’-AT GCT -3’) and 
D4AerR (5’- AT GCA…….-3’) to amplify 
another segment, ~650-bp coding for 
domain 4 of aerolysin gene, from A. 
hydrophila AHMP (Table 2). 
PCR assay was performed using a 
PCR mixture containing 3 µl of template 
DNA (100 nM) and 2 µl of 10 mM 
deoxynucleoside triphosphate (dNTP), 3 
µl of the 25 mM MgCl2 solution, 2 µl of 
the 20 mM solution of each primer, 0.3 µl 
of Taq polymerase (5u/µl), 5 µl of 10 × 
PCR buffer and 32.70 µl of dH2O water, to 
make the final volume of 50 µl. The 
amplification program consisted of 27 
cycles of amplification under the following 
condition: an initial denaturation of 5 
minutes at 95 C followed by 27 cycles 
each of 1 minute at 95 C, 1 minute at 60 
C and 1 minute at 72 C and additional 
final extension at 72 C for 10 minutes. 
Finally, 10 µl of PCR product was loaded 
on electrophoresis gel. 
Plasmid Extraction, Lactocccus lactis 
NZ9000 Competent Cell Preparation, 
RE Digestion and Ligation 
Plasmids pNZ8048 from L. lactis 
pNZ8048 and recombinant plasmids, 
pNZ8048D1Aer and pNZ8048D4Aer from 
L. lactis transformants (Table 1) were 
extracted according to Leenhouts and 
Venema 1993 with minor modification. 
Preparation of L. lactis NZ9000 competent 
cells was done according to the published 
method (Holo and Nes, 1989). A 24 hours 
old L. lactis NZ9000 colony was cultured 
in SGM17 (M17 with 0.5 M sucrose and 
0.5% glucose) supplemented with 1.5% 
glycine and incubated at 30º C for 24 
hours. One ml of an overnight culture was 
added into 100 ml fresh SGM17 + 1.5% 
glycine and incubated at 30º C, a few 
hours until the OD600 of 0.3-0.6 was 
achieved. 
The cells were then collected by 
centrifugation at 3500 rpm for 10 min at 4º 
C and washed twice with half volume ice-
cold 0.5 M sucrose with 15% glycerol. 
Centrifugation was done again before the 
cells were resuspended in 1/200 culture 
volume of 0.5 M sucrose with 15% 
glycerol. While preparing competent cells, 
it is very important that the cells are kept 
cold at all times. A volume of 40 µl of cell 
suspensions were transferred to fresh 1.5 
ml tube and kept in -80°C until usage for 
electro-transformation (electroporation).  
Restriction enzyme (RE) digestion 
mixture was included of 1 µg of substrate 
DNA (PCR product or plasmid), 2 µl of 
10X RE reaction buffer, 1 µl of enzyme 1 , 
1 µl of enzyme 2 and an appropriate 
volume of sterile water to make up a total 
volume of  20 µl. The reaction mixtures 
were incubated according to the RE’s 
optimum temperature, 37° C for 3 hours. 
Ligation of double stranded DNA 
contained 1 unit of T4 DNA Ligase 
(Fermentas), 2 l of 10X ligase buffer, 
1000 ng of vector DNA, 5 folds excess of 
insert and sterile distilled water to make up 
a final volume of 20 μl. The reaction 
mixture was incubated at 16 C for 8 
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hours. The recombinant plasmids were 
excised from the agarose gel (1% (w/v)) 
and purified with Gel Purification Kit 
(Qiagen, Germany) according to the 
protocol.  
Transformation of Recombinant 
pNZ8048 Plasmids into Lactococcus 
lactis NZ9000 and Verification 
A total of 3–5 l of the overnight ligation 
mixture was then used to transform the L. 
lactis NZ9000 competent cells by 
electroporation. Different recombinant L. 
lactis pNZ8048 plasmids produced in this 
work (pNZ8048D1Aer and 
pNZ8048D4Aer) which carried virulence 
genes of A. hydrophila were transformed 
into L. lactis according to the proposed 
protocol (Holo and Nes 1989) with minor 
modification. A volume of 10 µl of 
ligation mixture (about 1 µg of DNA 
plasmid) was mixed with 40 µl of 
aliquoted competent cells. 
The mixture was transferred into an 
ice-cooled electroporation cuvette (2mm 
electrode gap) and exposed to a single 
electrical pulse at 2.3 kV (capacitance of 
25 µF and resistance of 200 Ω). The 
electrical pulse was delivered using 
BioRad, the USA Gene Pulser 
Electroporation System equipped with a 
pulse controller unit. Immediately after the 
discharge, electroporated cells were mixed 
with 960 μl of ice-cold SGM17MC broth 
(SGM17 + 20 mM MgCl2 + 2mM CaCl2) 
and left on ice for 10 mins. 
The electroporated cells were then 
incubated at 30° C without shaking for 2- 
3 hours to allow for phenotypic 
expression. A volume of 100 μl of the cells 
was then spread on SGM17 agar 
containing chloramphenicol at a final 
concentration of 7.5 μg.ml-1 and incubated 
at 30 ºC for 2-3 days. A few well-isolated 
colonies were sub-cultured onto fresh 
SGM17 agar plates containing 7.5μg.ml-1 
chloramphenicol. Transformants were then 
cultured in SGM17 broth for plasmid 
extraction and analysis. Verification of 
cloning of the genes of interest into L. 
lactis was carried out using REs digestion 
analysis and DNA sequencing. 
 
Results 
PCR Amplification of the genes of 
interest 
Primers were designated (Table 2) 
according to the published sequences by 
(Wang et al., 2003; Rossjohn et al., 1997) 
to amplify two domains, domain 1 and 4 of 
aerolysin gene from A. hydrophila AHMP 
isolated from infected fish. The sizes of 
the genes of interest, domain 1 and domain 
4 of aerolysin from A. hydrophila were 
around 250 bps and 650 bps respectively. 
In addition, specific RE sites, PstI and 
HindIII had been placed in all forward and 
reverse primers respectively, for 
directional cloning into L. lactis 
expression vector, pNZ8048. Amplified 
PCR products were analysed with 1% 
agarose gel electrophoresis and results 
showed that amplifications were very 
specific (Fig. 1). In comparison with DNA 
markers, the sizes of the amplified PCR 
products were determined to be 
approximately 250 bps and 650 bps 
respectively. These bands, ~250 and ~650 
bps (Fig. 1, Lines 1, 2, 3) completely 
agreed with the expected values. The 
specific bands relevant to the expected 
sizes indicated that primers for 
amplification of domain 1 and domain 4 of 
aerolysin gene have high efficiency and 
specificity. 
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Figure 1: Agarose gel electrophoresis of PCR amplification 
products of the virulent genes, two domains of 
aerolysin from A. hydrophila  AHMP  
M: Marker, 1 kb DNA ladder., Lanes 1& 2:  PCR products of domain1 of aerolysin 
gene from A. hydrophila., Lane 3: PCR amplification of domain4of aerolysin  gene 
from A. hydrophila  
 
Cloning and transformation of the genes 
of interest into gram-positive bacteria, 
L. lactis NZ9000 
The amplified DNA bands of interest were 
excised from the gel at ~650 bps and ~250 
bps position. These PCR products were 
then purified using the DNA purification 
kit, digested with restriction enzymes (Pst 
I and Hind III) and ligated with linearised 
pNZ8048 plasmid using T4 DNA ligsase. 
Transformation of L. lactis NZ9000 cells 
was performed according to the protocol 
from Holo and Nes (1989). Figure 2 shows 
the maps of cloning of domain 1 of 
aerolysin into pNZ8048 vector, which 
D1Aer is domain 1 of aerolysin gene and 
contains from 211 bp to 433 bps and also 
Pst I with Hind III RE sites. Similarly, 
figure 3 shows the maps of cloning of 
domain 4 of aerolysin into pNZ8048 
vector, which D4aer is domain 4 of 
aerolysin containing from 211 to 855 bps. 
Maps were made by Clone Manager 
Computer Software. Ten to fifteen well-
grown colonies of each transformant cell 
types were selected and subjected to 
plasmid analysis. Figure 4 shows the RE 
digestion analysis of both recombinant 
(pNZ8048D4Aer and pNZ8048D1Aer) 
and non-recombinant pNZ8048 plasmids. 
Verification for cloning of the virulent 
genes was performed by REs digestion and 
DNA sequencing. Figure 4 shows the 
pattern of RE digestion of recombinant 
and non-recombinant pNZ8048 plasmids. 
Line 1 is recombinant pNZ8048D4Aer 
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with single digestion. Line 3 is non-
recombinant pNZ8048 plasmid with single 
digestion. Upon double digestion of 
transformant pNZ8048D1Aer plasmids 
with Hind III and Pst I, the molecular sizes 
of ~3340 bps and ~650 bps were shown by 
gel electrophoresis (Fig. 4, L2). These sizes 
correlated to the estimated and expected 
data. Therefore, the size and orientation of 
this putative clone obtained was in 
agreement with the expected recombinant, 
confirming the presence of domain 4 of 
aerolysin gene from A. hydrophila AHMP 
insert in pNZ8048 expression vector. 
Similarly, double digestion of line 7 shows 
cloning and presence of domain 1 of 
aerolysin gene from A. hydrophila AHMP 
insert in pNZ8048 expression vector. 
Further verification was carried out by 
DNA sequencing using the primers of the 
genes of interest. Blast analysis showed 
97% similarity between sequences of 
domain 1 and domain 4 of aerolysin gene 
with the published data respectively (Sasan 
2007).
 
 
Figure 2: Map of pNZ8048D1Aer construct indicating the site 
of the insertion of the domain 1 of aerolysin 
(D1Aer) gene and the orientation of this gene 
The vector contains nis promoter, start of an open reading 
frame, MCS, cmr, chloramphenicol resistance gene 
(Kuipers, 1998). 
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Figure 3: Map of pNZ8048D4Aer construct indicating the site of 
the insertion of the domain 4 of aerolysin (D4Aer) gene and the 
orientation of this gene.  
The vector contains nis promoter, start of an open reading frame, MCS, cmr, 
chloramphenicol resistance gene. 
 
 
Figure 4: Cloning of virulent genes, aerolysin 1&4 domains genes, 
of A. hydrophila AHMP into L lactis NZ9000. 
Lane 2: Double digestion of recombinant pNZ8048D4Aer plasmid with HindIII and PstI 
containing the domain 4 of aerolysin gene. Lane 7: Double digestion of recombinant 
pNZ8048D1Aer plasmid with HindIII and PstI containing domain 1 of aerolysin gene. 
Lanes M: 1 kb DNA Marker, #SM0311. 
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Discussions 
In this study, primers for the amplification 
of domain 1 and domain 4 of aerolysin 
gene from A. hydrophila were designated 
and PCR analysis verified to be very 
specific. The genes of interest were then 
cloned into pNZ8048, as L. lactis 
expression vector for the first time using 
electroporation method. Cloning 
verification was carried out by restriction 
enzyme digestion and DNA sequencing. 
Aerolysin is a well-known pore-forming 
toxin protein and major virulence factor 
that was first
 
purified from gram-negative 
pathogen A. hydrophila bacterium, and is 
capable of killing target cells by forming 
channels
 
in their membranes. It has been 
also reported that some domains of 
aerolysin protein especially domain 1 and 
4 have main roles in its pathogenicity 
(Abrami et al., 2000). In addition, results 
indicated that this toxin molecule had 
hemolytic, cytotoxic and enterotoxic 
activities (Pollard et al., 1990; Chopra et 
al., 1993). Moreover, recent studies have 
shown that aerolysin protein is capable of 
neutralizing human immunodeficiency 
virus type 1 (HIV-1) in a dose-dependent 
manner with neutralization dependent 
upon the presence of the Thy 1 proteins in 
the viral envelope (Nguyen et al., 1999). 
Furthermore, it has been shown that 
mutant strains of A. hydrophila deficient in 
aerolysin production were found to be less 
virulent than the wild type. Additionally, 
specific neutralizing antibodies to 
aerolysin have been detected in animals 
surviving Aeromonas infection (Leung et 
al., 1997; Leung and Stevenson, 1988). 
 Lactic acid bacteria (LAB) 
include a large number of gram-positive 
cocci or bacilli belonging to a 
phylogenetically heterogeneous group. 
Their traditional use in food industry 
confirms their lack of pathogenicity; as 
they are considered to be generally 
regarded as safe (GRAS) organisms. This 
group of bacteria has some advantages 
such as production of heterologous 
proteins in bio-reactors, in fermented food 
products or directly in the digestive tract of 
humans and other animals. Besides such 
natural benefits, a new application for 
LAB, and probably the most promising, is 
their use as live delivery vectors for 
antigenic or therapeutic protein delivery to 
mucosal surfaces. Such engineered LABs 
are able to elicit both mucosal and 
systemic immune responses. Some studies 
have shown and confirmed the efficiency 
of L. lactis for the presentation of antigens 
to the mucosal immune system, to elicit a 
specific response (Raha et al., 2006; 
Naima et al., 2007). 
Interestingly, several homologous 
and heterologous genes, a few antigens 
(bacterial and viral) and cytokines have 
been successfully expressed in L. lactis 
(Enouf et al., 2001; Chatel et al., 2003). 
Some of them include several lysozyme 
genes, the B. subtilis neutral protease (van 
de Guchte et al., 1989, 1990, 1992) tetanus 
toxin fragments C protein (Wells et al., 
1993) protease (Sasan, 2010), manganese 
superoxide dismutase gene from E. coli 
(Roy et al., 1993), xylanase gene of B. 
subtilis (Raha et al., 2006) and genes 
encoding for pyruvate ecarboxylase and 
alcohol dehydrogenase of Zymomonas 
mobilis (Gold et al., 1996). A growing 
number of studies reported the implication 
of lactic acid bacteria in fish diseases, 
while vaccination is not yet fully 
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operational. One of the most promising 
and urgent applications of lactic acid 
bacteria is therefore to investigate their use 
both as probiotics against bacterial 
pathogens, and as sources of 
immunostimulants (Ringo et al., 1998; 
Mohammed et al., 2008).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
The potential of L. lactis acid 
bacteria as vaccine vectors has been 
demonstrated in several recent 
publications, such as Lactococcus lactis 
prototype vaccines against Brucella 
abortis, and Helicobacter pylori (Joes and 
seegers, 2002). Furthermore, L. lactis has 
been
 
extensively engineered for the 
production of heterologous therapeutic
 
proteins. It has already been
 
used as an 
antigen delivery vehicle for vaccination 
against
 
tetanus, virus and more recently, 
for treatment of murine colitis
 
(Chatel et 
al., 2003). For this, construction of such 
genetically engineered safe 
microorganisms which are made by 
current work may result in protecting 
living things against pathogens. Future 
work should include immunological study 
of fish response and introduction of 
multiple epitope recombinant vaccine.  
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